China Universal Asset Management Co., Ltd. Igm Biosciences, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.05 Billion
- Q1 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 6,835 shares of IGMS stock, worth $8,885. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,835
Previous 7,226
5.41%
Holding current value
$8,885
Previous $44,000
84.09%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding IGMS
# of Institutions
68Shares Held
15.1MCall Options Held
0Put Options Held
0-
Baker Bros. Advisors LP New York, NY4.1MShares$5.33 Million0.05% of portfolio
-
Siren, L.L.C. New York, NY3.26MShares$4.23 Million0.19% of portfolio
-
Redmile Group, LLC San Francisco, CA2.95MShares$3.84 Million0.4% of portfolio
-
Black Rock Inc. New York, NY883KShares$1.15 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY855KShares$1.11 Million0.0% of portfolio
About IGM Biosciences, Inc.
- Ticker IGMS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,969,000
- Market Cap $37.7M
- Description
- IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...